Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study.
Mostaza JM, García-Ortiz L, Suárez Tembra MA, Talavera Calle P, Chimeno García J, Escolar Pérez V, Díaz-Díaz JL, Manzano-Espinosa L, Catapano AL, Ray KK, Díaz Moya G, Pedro-Botet Montoya J; en representación del grupo de investigadores de SANTORINI España. Mostaza JM, et al. Among authors: pedro botet montoya j. Rev Clin Esp (Barc). 2024 Nov 28:S2254-8874(24)00150-4. doi: 10.1016/j.rceng.2024.11.004. Online ahead of print. Rev Clin Esp (Barc). 2024. PMID: 39613100
Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes.
Guardiola M, Rehues P, Amigó N, Arrieta F, Botana M, Gimeno-Orna JA, Girona J, Martínez-Montoro JI, Ortega E, Pérez-Pérez A, Sánchez-Margalet V, Pedro-Botet J, Ribalta J; Cardiovascular Disease Group of the Spanish Society of Diabetes. Guardiola M, et al. Eur J Clin Invest. 2024 Aug;54(8):e14214. doi: 10.1111/eci.14214. Epub 2024 Apr 13. Eur J Clin Invest. 2024. PMID: 38613414 Review.
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial.
Mostaza JM, Suárez-Fernández C, Cosín-Sales J, Gómez-Huelgas R, Brotons C, Araujo FP, Borrayo G, Ruiz E; VULCANO investigators. Mostaza JM, et al. BMC Cardiovasc Disord. 2022 Dec 22;22(1):560. doi: 10.1186/s12872-022-03013-w. BMC Cardiovasc Disord. 2022. PMID: 36550424 Free PMC article. Clinical Trial.
Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study.
Millán Núñez-Cortés J, Cases Amenós A, Ascaso Gimilio JF, Barrios Alonso V, Pascual Fuster V, Pedro-Botet Montoya JC, Pintó Sala X, Serrano Cumplido A. Millán Núñez-Cortés J, et al. Among authors: pedro botet montoya jc. Am J Cardiovasc Drugs. 2017 Apr;17(2):135-142. doi: 10.1007/s40256-016-0197-9. Am J Cardiovasc Drugs. 2017. PMID: 27837448 Free PMC article.
Delphi consensus on the diagnosis and management of dyslipidaemia in chronic kidney disease patients: A post hoc analysis of the DIANA study.
Cases Amenós A, Pedro-Botet Montoya J, Pascual Fuster V, Barrios Alonso V, Pintó Sala X, Ascaso Gimilio JF, Millán Nuñez-Cortés J, Serrano Cumplido A. Cases Amenós A, et al. Among authors: pedro botet montoya j. Nefrologia. 2016 Nov-Dec;36(6):679-686. doi: 10.1016/j.nefro.2016.07.002. Epub 2016 Sep 30. Nefrologia. 2016. PMID: 27697414 Free article. English, Spanish.
[To improve cardiovascular health: we are forced for not loosing impulse].
Millán Núñez-Cortés J, Mantilla Morató T, Lobos Bejarano JM, Pedro-Botet Montoya J. Millán Núñez-Cortés J, et al. Among authors: pedro botet montoya j. Clin Investig Arterioscler. 2016 Jan-Feb;28(1):43-6. doi: 10.1016/j.arteri.2015.10.001. Epub 2015 Nov 14. Clin Investig Arterioscler. 2016. PMID: 26589871 Spanish. No abstract available.
[Atherogenic dyslipidemia and residual risk. State of the art in 2014].
Millán Núñez-Cortés J, Pedro-Botet Montoya J, Pintó Sala X; Residual Risk Reduction Initiative y Grupo de Trabajo sobre Dislipemia Aterogénica. Millán Núñez-Cortés J, et al. Among authors: pedro botet montoya j. Clin Investig Arterioscler. 2014 Nov-Dec;26(6):287-92. doi: 10.1016/j.arteri.2014.09.004. Epub 2014 Oct 31. Clin Investig Arterioscler. 2014. PMID: 25450326 Spanish.
[Dyslipidemias: a pending challenge in cardiovascular prevention. Consensus document from CEIPC/SEA Committee].
Royo Bordonada MÁ, Lobos Bejarano JM, Millán Núñez-Cortés J, Villar Álvarez F, Brotons Cuixart C, Camafort Babkowski M, Guijarro Herráiz C, de Pablo Zarzosa C, Pedro-Botet Montoya J, Santiago Nocito Ad; en nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC). Royo Bordonada MÁ, et al. Among authors: pedro botet montoya j. Med Clin (Barc). 2011 Jun 11;137(1):30.e1-30.e13. doi: 10.1016/j.medcli.2011.02.008. Epub 2011 Apr 20. Med Clin (Barc). 2011. PMID: 21511309 Spanish.
[Informed consent: opinions of health care personnel from a teaching hospital].
Iglesias Lepine ML, Pedro-Botet Montoya J, Pallás Villaronga O, Hernández Leal E, Echarte JL, Solsona Durán JF. Iglesias Lepine ML, et al. Among authors: pedro botet montoya j. Rev Clin Esp. 2007 Nov;207(10):483-8. doi: 10.1157/13111545. Rev Clin Esp. 2007. PMID: 17988593 Spanish.
28 results